Cargando…

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is a highly heterogeneous group of cancers, and molecular subtyping is necessary to better identify molecular-based therapies. While some classifiers have been established, no one has integrated the expression profiles of long noncoding RNAs (lncRNAs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yi-Rong, Jiang, Yi-Zhou, Xu, Xiao-En, Yu, Ke-Da, Jin, Xi, Hu, Xin, Zuo, Wen-Jia, Hao, Shuang, Wu, Jiong, Liu, Guang-Yu, Di, Gen-Hong, Li, Da-Qiang, He, Xiang-Huo, Hu, Wei-Guo, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791797/ https://www.ncbi.nlm.nih.gov/pubmed/26975198 http://dx.doi.org/10.1186/s13058-016-0690-8

Ejemplares similares

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
por: Liu, Yin, et al.
Publicado: (2023)

ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy
por: Li, Jian-wei, et al.
Publicado: (2014)

Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis
por: Li, Jia-Wei, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
por: Jiang, Yi-Zhou, et al.
Publicado: (2020)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
por: Yu, Ke-Da, et al.
Publicado: (2016)

Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype
por: Yu, Ke-Da, et al.
Publicado: (2015)

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation
por: Jin, Xi, et al.
Publicado: (2019)

Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers
por: Limsakul, Praopim, et al.
Publicado: (2023)

Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer
por: Glaß, Markus, et al.
Publicado: (2020)

A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
por: Tseng, Ling-Ming, et al.
Publicado: (2017)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
por: Chen, Qingwang, et al.
Publicado: (2022)

Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes
por: Zhao, Hongying, et al.
Publicado: (2021)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
por: Masuda, Hiroko, et al.
Publicado: (2017)

Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications
por: Zhao, Weihong, et al.
Publicado: (2014)

Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes
por: Su, Xiaoping, et al.
Publicado: (2014)

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype
por: Huang, Xiaoyan, et al.
Publicado: (2015)

Comprehensive Assessment of Subtyping Methods for Improved Surveillance of Foodborne Salmonella
por: Pan, Hang, et al.
Publicado: (2022)

Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer
por: Zhang, Haichao, et al.
Publicado: (2023)

Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs
por: Feng, Yuwei, et al.
Publicado: (2022)

Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer
por: Zoppino, Felipe C. M., et al.
Publicado: (2018)

Comprehensive analysis of angiogenesis subtype of squamous cell carcinoma
por: Qin, Fanglu, et al.
Publicado: (2021)

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype
por: Qin, Na, et al.
Publicado: (2020)

Integrative Analysis Reveals Subtype-Specific Regulatory Determinants in Triple Negative Breast Cancer
por: Huang, Shujun, et al.
Publicado: (2019)

Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology
por: Zhao, Yinjun, et al.
Publicado: (2018)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

Comprehensive Analysis of Cuproptosis Genes and Identification of Cuproptosis Subtypes in Breast Cancer
por: Li, Jialin, et al.
Publicado: (2023)

Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2022)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
por: Tong, Ling, et al.
Publicado: (2023)

Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
por: Hu, Xin, et al.
Publicado: (2021)

Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype
por: Shao, Fangyuan, et al.
Publicado: (2017)

The immune subtypes and landscape of sarcomas
por: Weng, Weiwei, et al.
Publicado: (2022)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c19qorasbsolkjd8339i6f6n22